Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Pritchett, James ^a,c   Athwal, Varinder S ^a,c   Harvey, Emma ^a   Martin, Katherine ^a,c   Llewellyn, Jessica ^a,c   Ireland, Philip ^a   Nicolaides, Alexander ^a   Humphries, Martin J ^d   Bobola, Nicoletta ^b   Hanley, Neil A ^a,c   Hanley, Karen Piper ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGENASE 3; OSTEOPONTIN; SMALL INTERFERING RNA; SYNTAXIN 2; TRANSCRIPTION FACTOR SOX9; COLLAGEN; EPIM PROTEIN, RAT; MEMBRANE PROTEIN; PEPTIDE HYDROLASE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VITRO STUDY; LIVER FIBROSIS; MALE; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN EXPRESSION; RAT; STELLATE CELL; ANIMAL; BINDING SITE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LIVER CIRRHOSIS; METABOLISM; NUCLEOTIDE MOTIF; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN DEGRADATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; COLLAGEN; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 13; MEMBRANE GLYCOPROTEINS; NUCLEOTIDE MOTIFS; PEPTIDE HYDROLASES; PROTEIN BINDING; PROTEOLYSIS; RATS; SOX9 TRANSCRIPTION FACTOR;

EID: 84903528063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100091     Document Type: Article

References (46)

1. Cohen-Naftaly M, Friedman SL (2011) Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol 4: 391-417.
2. Friedman SL, Sheppard D, Duffield JS, Violette S (2013) Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 5: 167sr161.
3. Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
4. Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539-548.
5. Pritchett J, Athwal V, Roberts N, Hanley NA, Hanley KP (2011) Understanding the role of SOX9 in acquired diseases: lessons from development. Trends Mol Med 17: 166-174.
6. Piper Hanley K, Oakley F, Sugden S, Wilson DI, Mann DA, et al. (2008) Ectopic SOX9 Mediates Extracellular Matrix Deposition Characteristic of Organ Fibrosis. Journal of Biological Chemistry 283: 14063-14071.
7. Pritchett J, Harvey E, Athwal V, Berry A, Rowe C, et al. (2012) Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology 56: 1108-1116.
8. Huang W, Zhu G, Huang M, Lou G, Liu Y, et al. (2010) Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects. Clin Chim Acta 411: 675-678.
9. Xie H, Song J, Du R, Liu K, Wang J, et al. (2007) Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma. Dig Liver Dis 39: 167-172. (Pubitemid 46117934)
10. Zhao L, Li T, Wang Y, Pan Y, Ning H, et al. (2008) Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract 62: 1056-1062. (Pubitemid 351793583)
11. Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, et al. (2011) Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53: 106-115.
12. Iredale JP (2001) Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 21: 427-436.
13. Hirai Y, Takebe K, Takashina M, Kobayashi S, Takeichi M (1992) Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell 69: 471-481.
14. Radisky DC, Hirai Y, Bissell MJ (2003) Delivering the message: epimorphin and mammary epithelial morphogenesis. Trends Cell Biol 13: 426-434. (Pubitemid 36897647)
15. Jia Y, Yao H, Zhou J, Chen L, Zeng Q, et al. (2011) Role of epimorphin in bile duct formation of rat liver epithelial stem-like cells: involvement of small G protein RhoA and C/EBPbeta. J Cell Physiol.
16. Zhou J, Zhao L, Qin L, Wang J, Jia Y, et al. (2011) Epimorphin regulates bile duct formation via effects on mitosis orientation in rat liver epithelial stem-like cells. PLoS One 5: e9732.
17. Radisky DC, Stallings-Mann M, Hirai Y, Bissell MJ (2009) Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat Rev Mol Cell Biol 10: 228-234.
18. Segawa D, Miura K, Goto T, Ohshima S, Mikami K, et al. (2005) Distribution and isoforms of epimorphin in carbon tetrachloride-induced acute liver injury in mice. J Gastroenterol Hepatol 20: 1769-1780. (Pubitemid 43961086)
19. Hirose M, Watanabe S, Oide H, Kitamura T, Miyazaki A, et al. (1996) A new function of Ito cells in liver morphogenesis: evidence using a novel morphogenic protein, epimorphin, in vitro. Biochem Biophys Res Commun 225: 155-160. (Pubitemid 26285412)
20. Zhou J, Zhao L, Qin L, Wang J, Jia Y, et al. (2010) Epimorphin regulates bile duct formation via effects on mitosis orientation in rat liver epithelial stem-like cells. PLoS One 5: e9732.
21. Yoshino R, Miura K, Segawa D, Hirai Y, Goto T, et al. (2006) Epimorphin expression and stellate cell status in mouse liver injury. Hepatol Res 34: 238-249.
22. Miura K, Yoshino R, Hirai Y, Goto T, Ohshima S, et al. (2007) Epimorphin, a morphogenic protein, induces proteases in rodent hepatocytes through NF-kappaB. J Hepatol 47: 834-843. (Pubitemid 350051118)
23. Watanabe S, Hirose M, Wang XE, Ikejima K, Oide H, et al. (1998) A novel hepatic stellate (Ito) cell-derived protein, epimorphin, plays a key role in the late stages of liver regeneration. Biochem Biophys Res Commun 250: 486-490. (Pubitemid 28463906)
24. Yamada M, Oda T, Higashi K, Kushiyama T, Yamakami K, et al. (2010) Involvement of epimorphin in the repair of experimental renal fibrosis in mice. Lab Invest 90: 867-880.
25. Jia YL, Shi L, Zhou JN, Fu CJ, Chen L, et al. (2011) Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metallopro-teinase- 9 axis. Hepatology 54: 1808-1818.
26. Smart DE, Green K, Oakley F, Weitzman JB, Yaniv M, et al. (2006) JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation. Hepatology 44: 1432-1440. (Pubitemid 44953649)
27. Rowe C, Gerrard DT, Jenkins R, Berry A, Durkin K, et al. (2013) Proteomewide analyses of human hepatocytes during differentiation and dedifferentiation. Hepatology 58: 799-809.
28. Oakley F, Meso M, Iredale JP, Green K, Marek CJ, et al. (2005) Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 128: 108-120. (Pubitemid 40039963)
29. Piper Hanley K, Hearn T, Berry A, Carvell MJ, Patch AM, et al. (2010) In vitro expression of NGN3 identifies RAB3B as the predominant Ras-associated GTP-binding protein 3 family member in human islets. J Endocrinol 207: 151-161.
30. Donaldson IJ, Amin S, Hensman JJ, Kutejova E, Rattray M, et al. (2012) Genome-wide occupancy links Hoxa2 to Wnt-beta-catenin signaling in mouse embryonic development. Nucleic Acids Res 40: 3990-4001.
31. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM (1989) Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 264: 10756-10762. (Pubitemid 19161648)
32. Gaca MD, Zhou X, Issa R, Kiriella K, Iredale JP, et al. (2003) Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 22: 229-239. (Pubitemid 36802365)
33. Shimada H, Rajagopalan LE (2012) Employment of gene expression profiling to identify transcriptional regulators of hepatic stellate cells. Fibrogenesis Tissue Repair 5 Suppl 1: S12.
34. Sohara N, Znoyko I, Levy MT, Trojanowska M, Reuben A (2002) Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. J Hepatol 37: 214-221. (Pubitemid 34833083)
35. Hirai Y (1993) Molecular cloning of human epimorphin: identification of isoforms and their unique properties. Biochem Biophys Res Commun 191: 1332-1337.
36. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, et al. (2012) Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A 109: 9448-9453.
37. Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, et al. (2012) Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143: 1073-1083 e1022.
38. Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJ (1992) Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest 90: 282-287.
39. Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, et al. (1998) Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 153: 1895-1902. (Pubitemid 28550676)
40. Watanabe T, Niioka M, Hozawa S, Kameyama K, Hayashi T, et al. (2000) Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 33: 224-235. (Pubitemid 30485226)
41. Terasaki Y, Fukuda Y, Ishizaki M, Yamanaka N (2000) Increased expression of epimorphin in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 23: 168-174. (Pubitemid 30656425)
42. Hattori T, Muller C, Gebhard S, Bauer E, Pausch F, et al. (2010) SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 137: 901-911.
43. Nishimura R, Wakabayashi M, Hata K, Matsubara T, Honma S, et al. (2012) Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification. J Biol Chem 287: 33179-33190.
44. Friedman SL (2003) Liver fibrosis - from bench to bedside. J Hepatol 38 Suppl 1: S38-53.
45. Endo H, Niioka M, Sugioka Y, Itoh J, Kameyama K, et al. (2011) Matrix metalloproteinase-13 promotes recovery from experimental liver cirrhosis in rats. Pathobiology 78: 239-252.
46. Kim EJ, Cho HJ, Park D, Kim JY, Kim YB, et al. (2011) Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid. Mol Ther 19: 355-361.